Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium alone versus ipratropium + budesonide versus ipratropium + violet flower extract in intubated ICU patients
IRCT20120716010297N8Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ipratropium bromide and budesonide (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure, Heart rate and 5 more. Started Aug 2020; status: completed.
02
Drugs
ipratropium bromidebudesonide
Beyond the preview
Go deeper on IRCT20120716010297N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120716010297N8.